Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hart

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Archives of Virology|November 8, 2024
Use of antibodies against Epstein-Barr virus nuclear antigen 1 for detection of cellular proteins with monomethylated arginine residues that are potentially involved in viral transformationChristian Graesser, Ruth Nord, Heinrich Flaswinkel, et al.
Aging|March 25, 2017
MiR-34a-3p alters proliferation and apoptosis of meningioma cells <i>in vitro</i> and is directly targeting SMAD4, FRAT1 and BCL2Tamara V Werner, Martin Hart, Ruth Nickels, et al.
Cellular & Molecular Biology Letters|January 24, 2023
Outside the limit: questioning the distance restrictions for cooperative miRNA binding sitesCaroline Diener, Martin Hart, Claudia Fecher-Trost, et al.
The FEBS Journal|March 14, 2013
The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancerMartin Hart, Sven Wach, Elke Nolte, et al.
Angewandte Chemie (International Ed. in English)|May 19, 2017
Encapsulation and Polymerization of White Phosphorus Inside Single-Wall Carbon NanotubesMartin Hart, Edward R White, Ji Chen, et al.
Journal for Immunotherapy of Cancer|July 18, 2019
miR-34a as hub of T cell regulation networksMartin Hart, Barbara Walch-Rückheim, Lena Krammes, et al.
Plos One|June 4, 2015
Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic HyperplasiaPetra Leidinger, Andreas Keller, Lisa Milchram, et al.
Journal for Immunotherapy of Cancer|November 24, 2020
Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4<sup>+</sup>, CD8<sup>+</sup> T cells, and M1 macrophagesMartin Hart, Laura Nickl, Barbara Walch-Rueckheim, et al.
Nucleic Acids Research|March 2, 2019
An estimate of the total number of true human miRNAsJulia Alles, Tobias Fehlmann, Ulrike Fischer, et al.
International Journal of Cancer|July 21, 2012
Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinomaJaroslaw Szczyrba, Elke Nolte, Martin Hart, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Archives of Virology|November 8, 2024
Use of antibodies against Epstein-Barr virus nuclear antigen 1 for detection of cellular proteins with monomethylated arginine residues that are potentially involved in viral transformationChristian Graesser, Ruth Nord, Heinrich Flaswinkel, et al.
Aging|March 25, 2017
MiR-34a-3p alters proliferation and apoptosis of meningioma cells <i>in vitro</i> and is directly targeting SMAD4, FRAT1 and BCL2Tamara V Werner, Martin Hart, Ruth Nickels, et al.
Cellular & Molecular Biology Letters|January 24, 2023
Outside the limit: questioning the distance restrictions for cooperative miRNA binding sitesCaroline Diener, Martin Hart, Claudia Fecher-Trost, et al.
The FEBS Journal|March 14, 2013
The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancerMartin Hart, Sven Wach, Elke Nolte, et al.
Angewandte Chemie (International Ed. in English)|May 19, 2017
Encapsulation and Polymerization of White Phosphorus Inside Single-Wall Carbon NanotubesMartin Hart, Edward R White, Ji Chen, et al.
Journal for Immunotherapy of Cancer|July 18, 2019
miR-34a as hub of T cell regulation networksMartin Hart, Barbara Walch-Rückheim, Lena Krammes, et al.
Plos One|June 4, 2015
Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic HyperplasiaPetra Leidinger, Andreas Keller, Lisa Milchram, et al.
Journal for Immunotherapy of Cancer|November 24, 2020
Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4<sup>+</sup>, CD8<sup>+</sup> T cells, and M1 macrophagesMartin Hart, Laura Nickl, Barbara Walch-Rueckheim, et al.
Nucleic Acids Research|March 2, 2019
An estimate of the total number of true human miRNAsJulia Alles, Tobias Fehlmann, Ulrike Fischer, et al.
International Journal of Cancer|July 21, 2012
Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinomaJaroslaw Szczyrba, Elke Nolte, Martin Hart, et al.
Pageof 6